KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,716,661 | -49.5% | 339,328 | -16.4% | 0.00% | -100.0% |
| Q2 2023 | $9,331,755 | -3.5% | 405,905 | +24.4% | 0.00% | 0.0% |
| Q1 2023 | $9,668,921 | +62.9% | 326,322 | +37.2% | 0.00% | 0.0% |
| Q4 2022 | $5,935,538 | +57.9% | 237,802 | +37.7% | 0.00% | 0.0% |
| Q3 2022 | $3,760,000 | -42.9% | 172,750 | -48.3% | 0.00% | 0.0% |
| Q2 2022 | $6,580,000 | -16.2% | 334,149 | +80.2% | 0.00% | 0.0% |
| Q1 2022 | $7,850,000 | +50.6% | 185,483 | +125.9% | 0.00% | 0.0% |
| Q4 2021 | $5,214,000 | +1.4% | 82,125 | -6.2% | 0.00% | 0.0% |
| Q3 2021 | $5,142,000 | +66.5% | 87,561 | +37.5% | 0.00% | – |
| Q2 2021 | $3,089,000 | -77.3% | 63,688 | -81.8% | 0.00% | -100.0% |
| Q1 2021 | $13,630,000 | +1157.4% | 350,740 | +1906.2% | 0.00% | – |
| Q4 2020 | $1,084,000 | +627.5% | 17,483 | +277.8% | 0.00% | – |
| Q3 2020 | $149,000 | – | 4,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 639,059 | $37,538,000 | 24.22% |
| BVF INC/IL | 3,180,658 | $186,832,000 | 7.29% |
| Deer IX & Co. Ltd. | 615,895 | $36,178,000 | 3.72% |
| Asymmetry Capital Management, L.P. | 89,071 | $5,232,000 | 3.14% |
| Redmile Group, LLC | 2,793,708 | $164,102,000 | 2.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,260 | $21,103,000 | 1.77% |
| CLOUGH CAPITAL PARTNERS L P | 271,000 | $15,919,000 | 0.96% |
| Rock Springs Capital Management LP | 732,927 | $43,052,000 | 0.90% |
| Eagle Health Investments LP | 37,000 | $2,173,000 | 0.69% |
| Avidity Partners Management LP | 514,500 | $30,222,000 | 0.67% |